EXAMINE THIS REPORT ON ETIZOLAM

Ro4938581 is actually a nootropic drug invented in 2009 by a group Functioning for Hoffmann-La Roche, which acts as a subtype-selective inverse agonist at the α5 subtype in the benzodiazepine binding web site within the GABAA receptor. It's excellent selectivity for your α5 subtype and didn't create convulsant or anxiogenic effects in animal repo